INTT Quote, Financials, Valuation and Earnings

AXT has a net margin of -8.74% compared to inTest's net margin of -45.45%. inTest's return on equity of -0.1% beat AXT's return on equity of -7.08%.

inTest has a consensus price target of $10.50, signalling upside risk potential of 48.94%. On the other hand AXT has an analysts' consensus of $3.96 which suggests that it could grow by 65.69%. Given that AXT has higher upside potential than inTest, analysts believe AXT is more attractive than inTest.

inTest has a beta of 1.655, which suggesting that the stock is 65.54% more volatile than S&P 500. In comparison AXT has a beta of 2.072, suggesting its more volatile than the S&P 500 by 107.197%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AXT offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. AXT pays out -- of its earnings as a dividend.

inTest quarterly revenues are $26.6M, which are larger than AXT quarterly revenues of $19.4M. inTest's net income of -$2.3M is higher than AXT's net income of -$8.8M. Notably, inTest's price-to-earnings ratio is 25.91x while AXT's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.68x versus 1.08x for AXT. Usually stocks with elevated PS ratios are considered overvalued.

Entegris has a net margin of -8.74% compared to inTest's net margin of 8.14%. inTest's return on equity of -0.1% beat Entegris's return on equity of 8.64%.

inTest has a consensus price target of $10.50, signalling upside risk potential of 48.94%. On the other hand Entegris has an analysts' consensus of $98.86 which suggests that it could grow by 13%. Given that inTest has higher upside potential than Entegris, analysts believe inTest is more attractive than Entegris.

inTest has a beta of 1.655, which suggesting that the stock is 65.54% more volatile than S&P 500. In comparison Entegris has a beta of 1.275, suggesting its more volatile than the S&P 500 by 27.526%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Entegris offers a yield of 0.46% to investors and pays a quarterly dividend of $0.10 per share. inTest pays -- of its earnings as a dividend. Entegris pays out 20.69% of its earnings as a dividend. Entegris's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

inTest quarterly revenues are $26.6M, which are smaller than Entegris quarterly revenues of $773.2M. inTest's net income of -$2.3M is lower than Entegris's net income of $62.9M. Notably, inTest's price-to-earnings ratio is 25.91x while Entegris's PE ratio is 42.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.68x versus 4.10x for Entegris. Usually stocks with elevated PS ratios are considered overvalued.

FormFactor has a net margin of -8.74% compared to inTest's net margin of 3.74%. inTest's return on equity of -0.1% beat FormFactor's return on equity of 5.72%.

inTest has a consensus price target of $10.50, signalling upside risk potential of 48.94%. On the other hand FormFactor has an analysts' consensus of $37.38 which suggests that it could grow by 6.48%. Given that inTest has higher upside potential than FormFactor, analysts believe inTest is more attractive than FormFactor.

inTest has a beta of 1.655, which suggesting that the stock is 65.54% more volatile than S&P 500. In comparison FormFactor has a beta of 1.147, suggesting its more volatile than the S&P 500 by 14.738%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FormFactor offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. FormFactor pays out -- of its earnings as a dividend.

inTest quarterly revenues are $26.6M, which are smaller than FormFactor quarterly revenues of $171.4M. inTest's net income of -$2.3M is lower than FormFactor's net income of $6.4M. Notably, inTest's price-to-earnings ratio is 25.91x while FormFactor's PE ratio is 50.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.68x versus 3.59x for FormFactor. Usually stocks with elevated PS ratios are considered overvalued.

IPG Photonics has a net margin of -8.74% compared to inTest's net margin of 1.65%. inTest's return on equity of -0.1% beat IPG Photonics's return on equity of -9.35%.

inTest has a consensus price target of $10.50, signalling upside risk potential of 48.94%. On the other hand IPG Photonics has an analysts' consensus of $66.40 which suggests that it could fall by -9.82%. Given that inTest has higher upside potential than IPG Photonics, analysts believe inTest is more attractive than IPG Photonics.

inTest has a beta of 1.655, which suggesting that the stock is 65.54% more volatile than S&P 500. In comparison IPG Photonics has a beta of 0.900, suggesting its less volatile than the S&P 500 by 9.957%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IPG Photonics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. IPG Photonics pays out -- of its earnings as a dividend.

inTest quarterly revenues are $26.6M, which are smaller than IPG Photonics quarterly revenues of $227.8M. inTest's net income of -$2.3M is lower than IPG Photonics's net income of $3.8M. Notably, inTest's price-to-earnings ratio is 25.91x while IPG Photonics's PE ratio is 22.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.68x versus 3.37x for IPG Photonics. Usually stocks with elevated PS ratios are considered overvalued.